Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Psoriatic | 6 | 2021 | 17 | 3.660 |
Why?
|
Antirheumatic Agents | 7 | 2022 | 123 | 3.570 |
Why?
|
Spondylitis, Ankylosing | 5 | 2021 | 20 | 3.240 |
Why?
|
Spondylarthritis | 3 | 2021 | 8 | 2.020 |
Why?
|
Biological Products | 3 | 2019 | 121 | 1.170 |
Why?
|
Arthritis, Rheumatoid | 2 | 2019 | 262 | 0.970 |
Why?
|
Practice Patterns, Physicians' | 2 | 2019 | 726 | 0.800 |
Why?
|
Veterans | 4 | 2019 | 1749 | 0.790 |
Why?
|
Biological Therapy | 1 | 2020 | 21 | 0.670 |
Why?
|
Health Services Accessibility | 3 | 2024 | 604 | 0.660 |
Why?
|
HLA-B27 Antigen | 2 | 2017 | 6 | 0.620 |
Why?
|
Rheumatology | 1 | 2020 | 120 | 0.610 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2022 | 512 | 0.570 |
Why?
|
Terminology as Topic | 1 | 2017 | 222 | 0.500 |
Why?
|
United States Department of Veterans Affairs | 1 | 2019 | 672 | 0.490 |
Why?
|
Patient Compliance | 1 | 2018 | 469 | 0.470 |
Why?
|
Absenteeism | 1 | 2014 | 20 | 0.460 |
Why?
|
Arthritis | 1 | 2015 | 80 | 0.460 |
Why?
|
Psoriasis | 1 | 2015 | 48 | 0.450 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2017 | 684 | 0.450 |
Why?
|
Efficiency | 1 | 2014 | 63 | 0.440 |
Why?
|
Workload | 1 | 2014 | 145 | 0.420 |
Why?
|
Fatigue | 1 | 2014 | 191 | 0.420 |
Why?
|
Spondylarthropathies | 1 | 2012 | 2 | 0.420 |
Why?
|
Middle Aged | 11 | 2024 | 26884 | 0.380 |
Why?
|
United States | 8 | 2024 | 10866 | 0.380 |
Why?
|
Adult | 11 | 2024 | 29554 | 0.370 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2015 | 301 | 0.350 |
Why?
|
Electronic Health Records | 1 | 2017 | 722 | 0.350 |
Why?
|
Rheumatologists | 2 | 2021 | 9 | 0.340 |
Why?
|
Quality of Life | 4 | 2022 | 1936 | 0.330 |
Why?
|
Aged | 8 | 2024 | 19830 | 0.320 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2012 | 205 | 0.320 |
Why?
|
Drug Substitution | 2 | 2018 | 20 | 0.300 |
Why?
|
Smartphone | 2 | 2024 | 37 | 0.280 |
Why?
|
Male | 12 | 2024 | 61317 | 0.260 |
Why?
|
Retrospective Studies | 6 | 2021 | 16263 | 0.260 |
Why?
|
Mobile Applications | 2 | 2024 | 89 | 0.260 |
Why?
|
Humans | 15 | 2024 | 124705 | 0.230 |
Why?
|
Female | 11 | 2024 | 66577 | 0.220 |
Why?
|
Musculoskeletal Diseases | 1 | 2024 | 57 | 0.220 |
Why?
|
Utah | 2 | 2014 | 47 | 0.220 |
Why?
|
Rheumatic Diseases | 1 | 2024 | 69 | 0.220 |
Why?
|
Databases, Factual | 2 | 2017 | 1176 | 0.200 |
Why?
|
Sacroiliac Joint | 1 | 2021 | 5 | 0.190 |
Why?
|
Patient Education as Topic | 1 | 2024 | 442 | 0.180 |
Why?
|
Spine | 1 | 2021 | 142 | 0.180 |
Why?
|
Drug Administration Schedule | 1 | 2022 | 715 | 0.170 |
Why?
|
Cohort Studies | 2 | 2021 | 4799 | 0.170 |
Why?
|
Injections | 1 | 2020 | 155 | 0.170 |
Why?
|
Patient Dropouts | 1 | 2018 | 52 | 0.150 |
Why?
|
Professional Practice Location | 1 | 2017 | 7 | 0.150 |
Why?
|
Time-to-Treatment | 1 | 2019 | 184 | 0.150 |
Why?
|
Poisson Distribution | 1 | 2017 | 50 | 0.140 |
Why?
|
Double-Blind Method | 1 | 2022 | 1637 | 0.140 |
Why?
|
Sacroiliitis | 1 | 2017 | 1 | 0.140 |
Why?
|
Medicare | 1 | 2021 | 424 | 0.140 |
Why?
|
Data Accuracy | 1 | 2017 | 25 | 0.140 |
Why?
|
Travel | 1 | 2017 | 113 | 0.130 |
Why?
|
Medication Adherence | 1 | 2021 | 393 | 0.130 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 306 | 0.130 |
Why?
|
Linear Models | 1 | 2017 | 682 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2018 | 381 | 0.120 |
Why?
|
Pain | 1 | 2018 | 450 | 0.120 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 2161 | 0.120 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 1159 | 0.120 |
Why?
|
Feasibility Studies | 1 | 2017 | 759 | 0.120 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 402 | 0.110 |
Why?
|
Algorithms | 1 | 2020 | 1625 | 0.110 |
Why?
|
Mortality | 1 | 2015 | 238 | 0.110 |
Why?
|
Disability Evaluation | 1 | 2014 | 192 | 0.110 |
Why?
|
Health Personnel | 1 | 2017 | 497 | 0.100 |
Why?
|
Anti-Inflammatory Agents | 1 | 2012 | 292 | 0.080 |
Why?
|
Surveys and Questionnaires | 2 | 2024 | 3715 | 0.080 |
Why?
|
Time Factors | 1 | 2019 | 6323 | 0.080 |
Why?
|
Follow-Up Studies | 1 | 2018 | 5154 | 0.080 |
Why?
|
Registries | 1 | 2014 | 1429 | 0.070 |
Why?
|
Comorbidity | 1 | 2012 | 1530 | 0.070 |
Why?
|
Incidence | 1 | 2014 | 3115 | 0.070 |
Why?
|
Aged, 80 and over | 1 | 2017 | 6584 | 0.070 |
Why?
|
Treatment Outcome | 1 | 2022 | 12364 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2014 | 2900 | 0.060 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 3415 | 0.060 |
Why?
|
Inflammation | 1 | 2012 | 1440 | 0.060 |
Why?
|
Community Mental Health Services | 1 | 2024 | 38 | 0.060 |
Why?
|
Patient Navigation | 1 | 2024 | 25 | 0.050 |
Why?
|
Mental Health Services | 1 | 2024 | 254 | 0.050 |
Why?
|